Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
161.24%Stock Based Compensation Margin
VS
Market
Sector
Industry
History
$ 5.34Close
$ 1.13 - $ 5.34 52-Week Range
Ticker Information
Ticker
TSHACompany Name
TAYSHA GENE THERAPIES INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQTAYSHA GENE THERAPIES INC - Stock Based Compensation Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
TSHA - SB Comp % Historical data
| Date | Revenues | Stock Based Compensation | Stock Based Compensation Margin |
|---|---|---|---|
| 6/30/2025 | $ 8.1M | $ 13.06M | 161.24% |
| 3/31/2025 | $ 7.22M | $ 13.2M | 182.71% |
| 12/31/2024 | $ 8.33M | $ 13.1M | 157.24% |
| 9/30/2024 | $ 9.91M | $ 11.86M | 119.57% |
| 6/30/2024 | $ 12.87M | $ 10.54M | 81.86% |
| 3/31/2024 | $ 14.16M | $ 9.43M | 66.6% |
| 12/31/2023 | $ 15.45M | $ 7.91M | 51.16% |
| 9/30/2023 | $ 14.35M | $ 10.04M | 69.97% |
| 6/30/2023 | $ 9.6M | $ 12.47M | 129.86% |
| 3/31/2023 | $ 7.21M | $ 14.39M | 199.63% |
Key Performance Insights, Last 5 Years
- TAYSHA GENE THERAPIES INC's latest trailing twelve months (TTM) SB Comp % stands at 0%.
- Over the past 5 years, TAYSHA GENE THERAPIES INC's average SB Comp % has been 176.45%.
- The median SB Comp % for TAYSHA GENE THERAPIES INC during this period was 129.86%
- TAYSHA GENE THERAPIES INC reached its highest SB Comp % over the past 5 years at 721.14%.
- The lowest SB Comp % recorded by TAYSHA GENE THERAPIES INC in the same timeframe 51.16%
TAYSHA GENE THERAPIES INC's SB Comp % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SB Comp % Benchmarks
Similar metrics to SB Comp %:
- Stock Based Compensation - [Cash Flow Statement] Stock Based Compensation, also called Share Based Compensation or Equity Compensation, is a method of paying directors, executives and employees with equity in the business. As non-cash expense, this element is added back when calculating net cash generated by operating activities [NCFO].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
Definition of Stock Based Compensation Margin
[Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].SB Comp. / Revenues
(=) SB Comp % SB Comp % for TAYSHA GENE THERAPIES INC is calculated as follows: SB Comp. [ $ 3.35M ] / Revenues [ $ 0 ]
(=) SB Comp % [ 0% ] TSHA - Stock Based Compensation Margin, Last 5 years
51.16%
Minimum
Dec 31, 2023
721.14%
Maximum
Dec 31, 2022
176.45%
Average
129.86%
Median
SB Comp % Benchmark AnalysisMarket
The chart above depicts the distribution of SB Comp % for companies in the Total Stock Market. The average SB Comp % of the companies is 1.72% with a standard deviation of 1.9%.
The following table provides additional summary stats:
SB Comp % in the Market:
| filtered constituents | 2.99K |
|---|---|
| min | -3.97% |
| max | 8.43% |
| average | 1.72% |
| median | 1.04% |
| std | 1.9% |